Clinical Trial Update: A Survey Of Clinical Practice Of Adjuvant Treatment Of Breast Cancer Using Exemestane (Aromasin®) In Postmenopausal Hr+ Patients

View source ↗

Summary

This clinical trial update describes clinical practice of using exemestane (Aromasin) as adjuvant therapy for postmenopausal, hormone receptor–positive breast c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Aromasin (exemestane)

Snippet

Sponsor: Pfizer | Conditions: Breast Cancer | Status: TERMINATED | Results posted: 2012-04-10